Artículos relacionados
Minoxidil oral en dosis bajas en alopecia frontal fibrosante: serie de 122 pacientes
El objetivo de nuestro estudio fue analizar la efectividad del minoxidil oral en dosis bajas (LDOM) en la línea del cabello frontotemporal en pacientes con alopecia frontal fibrosante (AFF). Se realizó un estudio retrospectivo, descriptivo […]
Prescribing Habits for Androgenetic Alopecia Among Dermatologists in Spain in 2024: A Cross-Sectional Study
The management of androgenetic alopecia (AGA) is evolving. This study updates current prescribing practices compared with 2019–2020. A digital survey was conducted among dermatologists in Spain between March and June 2024, focusing on AGA treatment […]
Low-Dose Oral Minoxidil as Treatment for COVID-19-Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients
Background and objective Coronavirus disease 2019 (COVID-19) associated telogen effluvium (CATE) has been observed in patients after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although it is self-limiting, hair loss can be very […]
